Description: - A unique collection of 2771 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;- Bioactivity and safety confirmed by pre-clinical research and clinical trials;- Targets include 5-HT receptor, AChR, Histamine receptor, dopamine receptor, Opioid receptor, etc;- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- Structurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;